CEO: Scott Drake
Headquarters: Cleveland, Ohio
Investment Date: July 2015
APO Financing: $29,400,000
Trading Venue: NASDAQ GM (VRAY)
ViewRay™ Incorporated of Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer. With the MRIdian system, physicians have more control over the delivery of their radiation therapy prescriptions. ViewRay technology provides continuous soft-tissue imaging during treatment, using MRI-guided radiation therapy, so that clinicians can see the target, monitor the radiation dose, and adapt to changes in the patient’s anatomy—all in real time.